QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Vol. 20, Issue 21, 4596-4610, November 1, 2009

This Article Abstract Full Text (PDF) Supplemental Materials All Versions of this Article: E09-03-0220v1 20/21/4596    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kong, T. Articles by Denker, B. M. Search for Related Content PubMed PubMed Citation Articles by Kong, T. Articles by Denker, B. M.

G12 Inhibits 2β1 Integrin–mediated Madin-Darby Canine Kidney Cell Attachment and Migration on Collagen-I and Blocks Tubulogenesis

Tianqing Kong^*, Daosong Xu, Wanfeng Yu^*, Ayumi Takakura^*, Ilene Boucher^*, Mei Tran^*, Jordan A. Kreidberg, Jagesh Shah^*, Jing Zhou^*, and Bradley M. Denker^*

*Renal Division, Brigham and Women's Hospital, Harvard Institutes of Medicine, Boston, MA 02115; Dana Farber Cancer Institute, Boston, MA 02115; and Children's Hospital, Boston, MA 02115

Submitted March 18, 2009; Revised August 19, 2009; Accepted September 15, 2009
Monitoring Editor: Asma Nusrat

	ABSTRACT

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Regulation of epithelial cell attachment and migration are essential for normal development and maintenance of numerous tissues. G proteins and integrins are critical signaling proteins regulating these processes, yet in polarized cells little is known about the interaction of these pathways. Herein, we demonstrate that G12 inhibits interaction of MDCK cells with collagen-I, the major ligand for 2β1 integrin. Activating G12 (QL point mutation or stimulating endogenous G12 with thrombin) inhibited focal adhesions and lamellipodia formation and led to impaired cell migration. Consistent with G12-regulated attachment to collagen-I, G12-silenced MDCK cells revealed a more adherent phenotype. Inhibiting Rho kinase completely restored normal attachment in G12-activated cells, and there was partial recovery with inhibition of Src and protein phosphatase pathways. G12 activation led to decreased phosphorylation of focal adhesion kinase and paxillin with displacement of 2 integrin from the focal adhesion protein complex. Using the MDCK cell 3D-tubulogenesis assay, activated G12 inhibited tubulogenesis and led to the formation of cyst-like structures. Furthermore, G12-silenced MDCK cells were resistant to thrombin-stimulated cyst development. Taken together, these studies provide direct evidence for G12–integrin regulation of epithelial cell spreading and migration necessary for normal tubulogenesis.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
The regulation of cell interactions with the extracellular matrix is a critical component of cell migration, and these processes are fundamental to normal tissue development, recovery from injury, and malignant transformation. Many signaling pathways have been implicated in the complex and highly coordinated sequence of events needed for cells to migrate, and these include heterotrimeric G proteins, receptor tyrosine kinases, monomeric G proteins (especially Rho), and integrins. However, the link between G protein signaling and integrins regulating cell migration has only been partially explored in hematopoietic cells, and very little is known about these pathways in other cell types, especially epithelia. Defining these pathways in epithelial cells is critical for understanding the metastatic potential of epithelial cell cancers, renal development, and other disorders such as autosomal dominant polycystic kidney disease (ADPKD) where cell attachment and migration contribute to the disease process (Joly et al., 2003; Battini et al., 2006; Boca et al., 2007).

The cell–matrix interaction involves an initial binding step that is then followed by cell spreading and the formation of focal adhesions and stress fibers (reviewed in Mitra et al., 2005). The interaction of the cell with the matrix is mediated by integrins, a large family of heterodimeric ( and β subunits) single transmembrane glycoproteins. There are at least 18 and 8β subunits that have been identified, and they assemble into 24 distinct integrins (reviewed in Hynes, 2002.) Many integrins can bind more than one ligand, but 1β1 and 2β1 are predominantly collagen receptors, whereas 4β1 and 6β1 recognize mainly laminins. These integrins are present in most types of epithelium, and they are localized to the apical and lateral membranes in addition to the basal surface. Heterotrimeric G proteins (four major families named for the G subunit (Gs, Gi/o, Gq, and G12/13) are ubiquitously expressed and signal through seven transmembrane receptors. Signaling through G proteins involves GTP binding to G, disassociation of G from Gβ and interaction with downstream effectors until the system is reset by the hydrolysis of GTP to GDP on G. Integrins and G proteins converge on common signaling pathways including Rho and nonreceptor tyrosine kinases such as Src. In hematopoietic cells and fibroblasts, some details of G protein regulation of migration through integrins have started to emerge. In splenic B-cells, lysophosphatidic acid regulated integrin-mediated adhesion through Gi and G12/13 pathways (Rieken et al., 2006), and in migrating leukocytes, the leading edge was dependent on Gi-mediated production of 3'-phosphoinositol lipids and activated Rac. The trailing edge used G12/13 regulation of Rho, and both systems coordinated differential regulation of the actin cytoskeleton in the presence of a chemoattractant (Xu et al., 2003). In platelets, integrin-mediated aggregation was stimulated with thrombin, ADP, epinephrine, thromboxane, and other agonists that utilize numerous G protein–coupled pathways. Costimulation of G12/13 and Gi pathways (with thromboxane A₂ and ADP) led to irreversible integrin (IIbβ3)-mediated aggregation (Dorsam et al., 2002; Nieswandt et al., 2002). In fibroblasts, G12/13 were required for directed cell migration in wound healing assays, and cells lacking G12/13 were unable to localize active Rho or its effector mDia at the wound edge (Goulimari et al., 2005).

G12/13 have major cellular roles that include regulating cell growth, transformation, and polarity (reviewed in Kelly et al., 2007). G12/13 also have unique functions regulating actin stress-fiber formation (Buhl et al., 1995; through direct activation of Rho; Kozasa et al., 1998) and of cell–cell adhesion through interactions with adherens junction protein, E-cadherin, and tight junction protein, ZO-1 (Meigs et al., 2002; Meyer et al., 2002). Therefore, G12/13 are well situated to modulate signaling events in epithelial cell migration, yet to date, little is known about these mechanisms. In addition, elevated G12/13 protein levels were described in prostate and breast cancer, and this was associated with increased invasion and metastasis but not proliferation (Kelly et al., 2006a,b). In the studies described here, we identify novel and specific regulation of epithelial cell attachment and migration through G12 and 2β1 integrin when grown on collagen-I. We have identified the major signaling pathways and mechanisms leading to loss of cell attachment and extend these observations in to a model of epithelial morphogenesis.

	MATERIALS AND METHODS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Cell Culture and Materials
The development and characterization of Tet-off inducible G12 and QL12 Madin-Darby canine kidney (MDCK) cell lines have been previously described (Meyer et al., 2002). Plasticware and tissue culture supplies were from BD Bioscience (San Jose, CA). Chemicals were from Sigma (St. Louis, MO) unless otherwise indicated. G12 antibody was from Santa Cruz Biotechnology (Santa Cruz, CA). Src pTyr-418 was from Invitrogen (Carlsbad, CA), and total c-Src was from Santa Cruz. 2 (5E8), 3 (A3-IIF5) and β1 (TS2/16) integrin antibodies were kindly provided by Dr. Martin Hemler (Harvard University; Zylstra et al., 1986; Kolesnikova et al., 2001). Collagen-IV was from BD Biosciences, and laminin-1 was from R&D Systems (Minneapolis, MN). Laminin-5 was provided by Martin Hemler, and Matrigel (BD Biosciences), fibronectin, and vitronectin were used as described previously (Yang et al., 2008). Collagen type-I rat tail was from BD Biosciences. PP2 {4-amino-5- (4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4,d]pyrimidine, Src Inhibitor} and Y27632 (Rho-associated protein kinase inhibitor) were from Calbiochem. Sodium orthovanadate was from Sigma. The 2β1 blocking antibody (mouse anti-human VLA-2) was from Chemicon (Temecula, CA; Wang and Frazier, 1998). Total focal adhesion kinase (FAK) antibody was from BD Biosciences. The phospho-FAK antibodies were included in a kit (Biosource, Camarillo, CA). An additional pFAK397 was from ECM Biosciences (Versailles, KY). Total Paxillin (H-114) was from Santa Cruz. Paxillin 118 was from Cell Signaling Technology (Beverly, MA).

Immunoprecipitation and Western Blot
G12- or QL12-expressing MDCK cells were cultured with or without (±) doxycycline (dox). Monolayers were scraped in lysis buffer (150 mM NaCl, 2.5 mM EDTA, 25 mM HEPES, pH 7.5, 1 mM PMSF, 1% Triton X-100, and protease inhibitors; Roche, Indianapolis, IN) and phosphatase inhibitor cocktail (Sigma) plus 1 mM NaVO₄ and 25 mM NaF, as needed for detection of phospho-proteins, frozen/thawed, triturated, and centrifuged. Immunoprecipitations of 2 integrin were done with protein A-Sepharose or goat affinity-purified rat IgG beads (MP Biomedicals, Aurora, OH) overnight at 4°C. Beads were centrifuged and washed three times, and proteins were eluted in SDS-PAGE sample buffer (nonreducing). SDS-PAGE was followed by Western blot transfer as previously described (Meyer et al., 2002). After blocking and washing, primary antibodies to FAK were added overnight followed by incubation with secondary horseradish peroxidase–conjugated antibodies for 1 h. Signal was detected with SuperSignal West Pico horseradish peroxidase substrate system (Pierce, Rockford, IL) and autoradiography (Biomax MR; Eastman Kodak, Rochester, NY).

Cell Attachment Studies
Plasticware was precoated with laminin-1 (10 µg/ml), laminin-5 (1:100), Matrigel (1:200), collagen-I (8.6 µg/ml), fibronectin (10 µg/ml), vitronectin (1:100), and collagen-IV (10 mg/ml). Bovine serum albumin (BSA; 10 mg/ml) was sterile-filtered, then heated to 85°C for 10 min, and cooled to room temperature (RT). One hundred microliters was added to a 96-well plate and incubated at 37°C for 30 min. MDCK cells were grown to 60–90% confluence under standard conditions, and washed twice with PBS, and Calcein Am (Invitrogen) stock (5 µl, in 1 ml of DMEM (serum free) was added to the cells and incubated at 37°C for 30 min. Cells were washed twice with PBS, and detached cells were counted, gently centrifuged for 5 min, and resuspended at 2.5 x 10⁵/ml. One hundred microliters was added to each well of a 96-well plate and incubated at 37°C for 20–30 min. Each well was washed three times with PBS, and fluorescence measured using a CytoFluor 2300, fluorimeter (Millipore, Bedford, MA). Each condition was performed with n = 4, and the experiment was repeated at least three times. Agonists (2 U/ml thrombin and 100 µM bradykinin) were added after cells were detached for 30 min and then were analyzed for adhesion to collagen-I.

FACS Analysis
G12- and QL12-MDCK cells± dox for 48 h were surface-labeled with antibodies to 2 and β1 integrin. Control antibody was mouse IgG (Sigma). Cells were grown to 90% confluence, washed once with PBS, and detached with detachment buffer. Cells were washed with PBS and filtered through a 40-µm sieve, and 5 x 10⁵/ml cells were suspended in each well of a 96-well plate (flat bottom) with fluorescence-activated cell sorting (FACS) buffer (5% heat-inactivated goat serum, 1% BSA, and 0.1% NaN₃ in PBS) and kept on ice for 1 h. Cells were then incubated with specific antibodies (10 µg/ml in FACS buffer) on ice for 1 h. Cells were washed three times in FACS buffer, centrifuged, and incubated with goat anti-mouse IgG-FITC (Biosource; 1:100 in FACS buffer) for 1 h. After washing with PBS, cells were resuspended and analyzed by FACS Calibur (BD Biosciences). Data were analyzed with FlowJo software Free Star, Ashland, OR), and each antibody staining was done with three wells and repeated at least three times.

Cell Spreading
Plasticware was coated with Collagen-I (8.6 µg/ml) at 37°C for 1 h. Plates were washed once with PBS and then blocked with BSA (10 mg/ml) for 30 min at 37°C. Cells were detached as described above but resuspended at 1 x 10⁵/ml, and 0.5 ml placed in each of the 24 wells. Cells were observed continuously for 20–40 min and then gently washed twice with PBS, fixed in paraformaldehyde (PFA; 4%), and stained with Giemsa (Sigma) (1:20 dilution in water for 30 min), washed three times with water, and then imaged.

Cell Invasion
Transwell filters (8-µm pore size, 6.5-mm diameter; Corning, Corning, NY) were coated with collagen-I as described above. Cells, 5 x 10⁴ in 100 µl serum free medium, were placed in the apical chamber, and 600 µl medium containing hepatocyte growth factor (HGF; 20 ng/ml; Sigma) was added to the bottom chamber. Cultures were incubated at 37°C overnight, washed twice with PBS, and then fixed with ice-cold methanol for 6 min. After air drying, cells were stained with Giemsa and the bottom surface of the filter photographed for cell migrating through the filter.

Scratch Wound Assay and Videomicroscopy
G12- and QL12-MDCK cells (±dox) were plated on a collagen-I coated 10-cm² plate. After reaching confluence, the surfaces were scratched with a 10-µl extended length pipette tip and maintained in a humidified chamber. Each condition was imaged on a Nikon TE 2000E2 microscope (Melville, NY), captured to a COOLSNAP HQ cooled CCD (Photometrics, Tucson, AZ), and analyzed with IPLab software (Scanalytics, Fairfax, VA). Images were obtained every 10 min. Wound closure rate was calculated by measuring the area of the gap over time using Image J (1.38, Wayne Rasband, NIH, http://rsb.info.nigh.gov/ij/). Tet-off MDCK cells were analyzed under identical conditions ± thrombin (2 U/ml) added to the medium at the time of scratching (t = 0).

Immunofluorescence and Confocal Microscopy
G12- and QL12-MDCK cells were cultured at subconfluent density on collagen-I–coated culture slide chambers (Falcon plates; BD Labware, Bedford, MA) for 48 h ± dox. Cultures were fixed with 3.7% PFA for 15 min, followed by ice-cold acetone for 10 min and two washes with PBS. Blocking was done for 1 h at RT with 1% BSA and 2% goat serum in PBS. Cultures were then washed three times with PBS followed by incubation with vinculin-FITC (mAb from Sigma, in 1% BSA in PBS, 1:50) for 1 h at RT. Cultures were washed three times with PBS and mounted with DAPI-containing mounting (Vector Laboratories, Burlingame, CA). Images were obtained using a Zeiss Confocal LSM510 microscope (Thornwood, NY) and figures were assembled as described above. Phalloidin staining (1:200) was done for 30 min under identical cell culture conditions. 2 and β1 integrin staining was performed using similar conditions and appropriate secondary antibodies.

RhoA Activation
Rho activation was determined using rhotekin-RBD (Rho-binding domain) beads according to the manufacturer's instructions (Cytoskeleton, Denver, CO). Briefly, subconfluent 10-cm² plates were placed in 1% serum for 8 h followed by 16 h in serum-free medium. Lysates were incubated with rhotekin beads at 4°C for 1 h. Beads were pelleted, washed, and eluted followed by Western blot for Rho A. Controls included incubating +dox lysates with GDP (1 mM, negative control) or GTPS (200 µM, positive control) for 15 min and then analyzing with parallel samples from wild-type and QL12-MDCK cells ± dox.

Inhibitor Studies
Cell Attachment, spreading, and invasion assays were performed in G12- and QL12-MDCK cells (±dox) and ±Src inhibitor (PP2 at 10 µM) or the Rho kinase inhibitor (Y27632, 10 µM) or phosphatase inhibitor (sodium orthovanadate at 100 µM). The inhibitors were added immediately after the cells were detached and kept in the suspension of detached cells for 30 min before replating and analysis in the different assays. Attachment, spreading, and invasion were performed as described above images for figures assembled in Adobe Photoshop and Illustrator (Adobe Systems, San Jose, CA) as described.

Stable Knockdown of G12 in MDCK Cells
G12-specific siRNAs (forward: 5'-GATCCCCGGGCATTGTGGAACATGACTTCAAGAGATGCATGTTCCACAATGCCCTTTTTGGAAA-3'; reverse: 5'-AGCTTTTCCAAAAAGGGCATTGTGGAACATGACTCTCTTGAAGTCATGTTCCACAATGCCCGGG-3') were cloned in to pSUPER vector using BglII and HindIII sites and standard techniques. A control pSUPER vector construct containing 64mer green fluorescent protein (GFP)-specific siRNA was used as negative control. In a ratio of 1:9, pSUPER vector (siG12 or control) was cotransfected with blasticidin resistance plasmid using FuGENE 6 (Roche) according to the manufacturer's instructions. After overnight incubation, selective medium containing 10 ng/µl blasticidin was added to the medium. Stable transfectants were selected from individual clones after 4 wks of selection in the presence of blasticidin. RNA isolation of shG12 or short hairpin (sh)GFP-silenced MDCK cells was obtained by TRIzol (Invitrogen). Total RNA was purified according to the manufacturer's protocol and quantified. Five micrograms of total RNA was reverse-transcribed using the Transcriptor Reverse Transcriptase Kit (Roche). Equal aliquots of cDNA were subsequently amplified for β-actin and G12. The oligonucleotide primer sequences used for β-actin and G12 were as follows: β-actin: sense, 5'-CGCTAGTTGTAGATAACGGCTC-3'; antisense, 5'-GCTTGCTGATCCACATCTGCTG-3'; and G12: sense, 5'-GTTCTTGTCGATGCCCGAGACA-3'; antisense, 5'-TCACTGCAGCATGATGTCCTTC-3'. After 30 cycles, the amplified fragments were resolved by electrophoresis on a 1% agarose gel and visualized by ethidium bromide staining using a Kodak DC290 zoom digital camera.

3D Tubulogenesis Assay
Tubulogenesis assays were performed according to the method of Pollack et al. (1998). Briefly, cells were grown to 60–80% confluence on 10-cm² dishes, trypsinized, and resuspended at a concentration of 4 x 10⁴ cells/ml in collagen-I, 10x DMEM, and HEPES (at 8:1:1) on ice. The single-cell suspension was plated on to slide chambers for 30 min at 37°C and allowed to solidify. Two milliliters of 10% FBS in tissue culture media with or without HGF (20 ng/ml; Sigma) was then placed on top. The medium was replaced every 2 d, cultures were photographed at 7 d, and images were assembled in Adobe Photoshop and Illustrator (Adobe Systems). For experiments with G12- and QL12-MDCK cells, parallel cultures were established ±dox (40 ng/ml).

Staining of MDCK Cells Cultured in 3D Collagen Gels
3D cultures were prepared as described above and then washed three times with PBS. 3D cultures were treated with collagenase (type VII 7, 500 U) for 10 min at 37°C. Slides were washed three times with PBS and fixed with 4% PFA for 30 min (with gentle shaking). Slides were washed three times with PBS followed by blocking buffer (1.6 ml 45% gelatin from cold water fish skin, Sigma; 1.25 ml saponin, Calbiochem in 100 ml PBS) for 30 min at RT. Slides were then stained with rat mAb to E-cadherin (Abcam, Cambridge, MA) at 1:50 in PFS at 4°C overnight. Slides were washed three times with PBS and incubated with Alexa 488 goat anti-rat IgG 1:1000 in blocking buffer overnight. Images were obtained using a Nikon confocal microscope, and images were assembled using Adobe Photoshop and Illustrator.

Quantification and Statistics
Western blots were scanned using an Epson 1640 desktop scanner (Long Beach, CA), and band intensity quantified using NIH Image (Wayne Rasband) after subtracting background and determining linear range. Statistics were done in GraphPad Prism (San Diego, CA). Significance was determined by using t test.

	RESULTS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
G12 Regulates MDCK Cell Interactions with Collagen-I through 2β1 Integrin
MDCK cells with inducible (Tet-off) expression of G12 or constitutively active G12 (QL) have been previously characterized (Meyer et al., 2002, 2003; Yanamadala et al., 2007; Sabath et al., 2008). Figure 1A shows the inducible G12 expression at 48 h after removal of doxycycline (–dox) in both G12- and QL12-MDCK cells. During routine culturing, we noticed that QL12-MDCK cells in –dox were less adherent to the plate. To determine if this depended on the substrate, we tested the interactions of control (Tet-off), wild-type G12-MDCK, and QL12-MDCK cells ± dox for interaction with various extracellular matrix components (Figure 1 and Supplemental Figure S1). BSA was used as a protein control for non-integrin–mediated interactions. Figure 1 shows attachment of Tet-off, G12-, and QL12-MDCK cells ± dox to collagen-I (Figure 1B), collagen-IV (Figure 1C), laminin-1 (Figure 1D), and fibronectin (Figure 1E). The attachment of MDCK cells to collagen-I was significantly reduced (58% of control) with G12 expression (–dox, Figure 1B) and with expression of activated G12 (QL12, –dox), attachment to collagen-I was further reduced (42% of control, Figure 1B). All of the MDCK cell lines interacted strongly with collagen-IV, but there was no demonstrable difference with G12 or QL12 expression (Figure 1C). On laminin-1, each MDCK cell line was adherent but only with QL12 expression (–dox) was there a significant loss of cell attachment (Figure 1D). In contrast, there was no specific binding of any of the MDCK cells ± dox to fibronectin when compared with BSA (Figure 1E). Supplemental Figure S1 shows interactions of G12-MDCK cells ± dox with Matrigel (Supplemental Figure S1A) and laminin-5 (Supplemental Figure S1B), and vitronectin (Figure 1C). Matrigel is composed predominantly of laminin-1, and the interaction of G12-MDCK cells on Matrigel was similar to what we observed with laminin-1 (Figure 1D). The adherence to vitronectin was similar to BSA and was not affected by G12 or QL12 expression (–dox; Supplemental Figure S1C). However, on laminin-5 we observed significant binding that was inhibited with QL12 expression (–dox) but not with expression of wild-type G12 (Supplemental Figure S1B). The findings with laminin-1, laminin-5, and Matrigel suggest G12 regulation of other integrins in epithelial cell attachment. Because collagen-I is ubiquitously expressed in all major organs and there was G12-dependent binding to collagen-I but not to collagen-IV, we focused our subsequent studies on 2β1 integrin and collagen-I.

View larger version (37K): [in this window] [in a new window]   Figure 1. Attachment to collagen-I is inhibited with G12 activation. (A) Western blot showing inducible G12 and QL12 expression in ±dox. G12- and QL12-MDCK cells were cultured ± dox for 48 h before preparation of cell lysates and 50 µg total protein analyzed by SDS-PAGE and Western blot as described in Materials and Methods. Attachment to collagen-I (B), collagen-IV (C), laminin-1 (D), and fibronectin (E). Tet-off, G12-, and QL12-MDCK cells ± dox were analyzed for attachment to various substrates as described in Materials and Methods. (F) Thrombin stimulates detachment in Tet-off MDCK cells. Identical numbers of Tet-off cells were stimulated with vehicle, thrombin (2 U/ml), or bradykinin (100 µM) for 30 min after detachment and subsequent plating on collagen-I. Attachment was measured as described above. (G) MDCK cell attachment to collagen-I was completely inhibited by preincubation with 2β1 integrin–blocking antibody (at 10 µg/ml) and unaffected by a control antibody. Significance, *p < 0.05.

Activation of G12 in MDCK Cells Cultured on Collagen-I Leads to Loss of Lamellipodia and Focal Adhesions
To further characterize the effect of G12/2β1 integrin signaling on MDCK cell phenotypes cultured on collagen-I, we compared MDCK cells with inducible expression of G12 and QL12 with Tet-off cells in cell spreading and migration assays. To examine cell spreading, cells were dissociated from a confluent monolayer and imaged 30 min after plating on to collagen-I. Figure 2A shows that control cells (Tet-off, G12 +dox, and QL12 +dox) develop cellular extensions and a flattened appearance within 30 min. However, in G12- or QL12-expressing cells (–dox) there was little or no cytoplasmic extension, and only the nuclei were visible in most cells. To further examine focal adhesions under these conditions, we stained subconfluent MDCK cells for vinculin. Figure 2B shows that vinculin is present in numerous focal adhesion complexes in Tet-off, G12-, and QL12-MDCK cells in +dox. With wild-type G12 expression (–dox; Figure 2B) vinculin staining was reduced but was still present in some areas (white arrow). With QL12 expression, the normal pattern of vinculin staining was significantly altered with nearly complete loss of staining (arrowheads). This finding suggests that QL12 activation of 2β1 integrin on collagen-I leads to defects in focal adhesion and lamellipodia formation. However, G12 expression (wild type and QL in –dox) still led to increased actin stress fiber formation as expected from activation of Rho pathways (Figure 2C and see Figure 6A).

View larger version (39K): [in this window] [in a new window]   Figure 2. Cell spreading and focal adhesions are inhibited with G12 activation. (A) Tet-off, G12-, and QL12-MDCK cells cultured ± dox for 72 h were detached as described in the Materials and Methods plated on to collagen-I coated plastic at T = 0. Cells were fixed and stained with Giemsa at T = 30 min. Arrows denote stained cells in the various conditions and small rounded cells were seen with in G12- and QL12-MDCK cells in –dox. (B) Vinculin staining of Tet-off and G12-, QL12-MDCK cells ± dox. Arrows denote punctate focal adhesion staining in the controls (Tet-off and +dox). Arrowheads in QL12–dox shows lack of focal adhesions. (C) Phalloidin staining of Tet-off and G12-, QL12-MDCK cells in ±dox. Arrows show actin at leading edge of lamellipodia in Tet-off and G12- and QL12-MDCK cells in +dox. Open arrow heads indicate increased stress fibers in G12- and QL12-MDCK in –dox.

Activating G12 Impairs Cell Migration

View larger version (81K): [in this window] [in a new window]   Figure 3. MDCK cell migration through a permeable membrane and in wound assays is inhibited with G12 activation. (A) Left (a–f), migration through Transwell filters. Equivalent numbers Tet-off, G12-, and QL12-MDCK cells in ±dox were plated into the apical chamber of collagen-I–coated Transwell filters (8 µm) as described in Materials and Methods. Cultures were incubated at 37°C overnight, and the basal surface of the filter fixed and stained for migrating cells. Arrows mark pores within the surface of the filter. There were virtually no cells visualized in the G12 and Q12 –dox conditions in comparison to the controls (e, f). Right, to quantify the relative migration, the number of cells visualized on the basal surface in 10 separate fields were counted and divided by the starting number of cells. Tet-off in +dox was used for the reference and set at 100. (B–D) Wound assays were performed as described in Materials and Methods for G12-MDCK ± dox (B) and QL12-MDCK cells ± dox (C), and Tet-off cells ± 2 U/ml thrombin (D) were added at time = 0. Images from specific times for each cell line are shown and the average open area calculated using Image J at each time point. For Tet-off cells without thrombin, the gap was closed by approximately 12 h. (E) The relative rates of closure for each condition. For Tet-off: , –thrombin; , + thrombin, which were set to 100%. The effect of thrombin () and G12 or QL12 expression (–dox, ) is shown relative to the control (+dox, ). Error bars are 95% confidence intervals for n = 2–3 experiments for each condition.

Knockdown of G12 in MDCK Cells Leads to Increased Attachment and Accelerated Spreading on Collagen-I
QL12 expression in MDCK cells or thrombin stimulation of endogenous G12 inhibited 2β1 integrin function and cell attachment to collagen-I. To confirm the essential role for G12 on this phenotype, we established MDCK cells with stable knockdown of endogenous G12 (Figure 4). Canine G12 was stably knocked down in MDCK cells using short hairpin RNA (shRNA) and compared it with a control cell line transfected with shRNA for GFP selected under identical conditions. Because endogenous G12 is not detectable in MDCK cell lysates by Western analysis, we utilized RT-PCR to assess the knockdown efficiency. Figure 4A shows the results of RT-PCR for G12 and actin in G12 knockdown (shG12-MDCK) and control cell lines (shRNA for GFP). G12 mRNA levels were 16 ± 8% of the GFP control when normalized to the simultaneous β-actin control. Comparison of the shG12-MDCK cells with shGFP and Tet-off controls revealed significantly increased attachment to collagen-I in the shG12-MDCK cells (Figure 4B). In addition, when the cell lines were analyzed for cell spreading after plating on to collagen-I, the control cells were still quite rounded and revealed few cellular extensions when compared with the shG12-MDCK cells imaged at the same time (Figure 4C).

View larger version (58K): [in this window] [in a new window]   Figure 4. Silencing G12 in MDCK cells increases attachment to collagen-I. (A) RT-PCR results of knockdown of G12 in stable cell line transfected with shRNA for G12 or control GFP shRNA as described in Materials and Methods. The G12 transcript was normalized to β-actin for each condition and reveals 16 ± 8% of the control G12 mRNA levels. (B) Attachment to collagen-I was compared for Tet-off, shG12-, and shGFP-MDCK cells as described above. Results were normalized to Tet-off condition. n = 3 and significance at *p < 0.02. (C) Photomicrographs of phase-contrast images from GFP control and silenced G12-MDCK cells taken 30 min after plating on collagen-I.

G12 Activation Disrupts 2β1 Integrin Localization without Affecting Protein Levels

View larger version (51K): [in this window] [in a new window]   Figure 5. 2 and β1 integrin membrane localization is altered with QL12 expression without affecting membrane expression. (A) Membrane expression of integrins. Tet-off, G12-, and QL12-MDCK cells were cultured ± dox for 72 h and then surface-labeled with antibodies to 2 and β1 integrins as described in Materials and Methods. Cells were then analyzed by FACS and sorted by intensity for specific integrin staining. The position along the X-axis reflects the amount of surface labeling and was not significantly different in any of the conditions. (B) Immunofluorescence microcopy of 2 and β1 integrins. G12- and QL12-MDCK cells (±dox) were stained with specific antibodies and imaged as described in Materials and Methods. Bar, 20 µm.

View larger version (58K): [in this window] [in a new window]   Figure 6. Rho and Src mediate G12-stimulated decreased attachment and disruption of the 2 integrin/FAK complex. (A) Rho activation in Tet-off, G12-, and QL12-MDCK cells ± dox. Rho activity was determined using Rhotekin GST pulldowns as described in Materials and Methods. Cell lysates from control cells were incubated with GDP (1 mM, negative control) or GTPS (200 µM, positive control). Pulldowns were analyzed for Rho by Western blot and lysates (50 µg) analyzed for total Rho. (B) Src tyrosine kinase activity in Tet-off, G12-, and QL12-MDCK cells ± dox. Approximately 50 µg of cell lysate was analyzed by Western blot for p-Tyr-418 and total Src. The results of two independent experiments are summarized in the bar graph; error bars, range. (C) Cell attachment to collagen-I for QL12-MDCK cells ± dox treated with the Rho kinase inhibitor (Y27632) or the Src inhibitor (PP2). (D) Cell spreading of QL12-MDCK cells ± dox cultured on collagen-I in the presence and absence of vehicle, Y27632, and PP2. Cells were detached, inhibitors were added, and cells were plated on collagen-I for 30 min, followed by fixation and nuclear staining with Giemsa. The loss of cellular extensions seen in –dox was inhibited with Rho kinase inhibition and partially with Src inhibition. (E) Activating G12 leads to disruption of 2 integrin and FAK complex in a Rho and Src-dependent manner. Tet-off, G12-, and QL12-MDCK cells ± dox were immunoprecipitated with 5E8 antibody to 2 integrin and then analyzed by Western blot for coprecipitating FAK (arrow). All of the lanes are assembled from the same gel and exposure. White lines indicate where conditions were regrouped. There is no detectable FAK in the 2 integrin immunoprecipitation from QL12-MDCK cells in –dox, and there was no detectable FAK precipitating with a nonspecific antibody (4F2). When the cells were preincubated with the Rho kinase inhibitor (Y27632) or the Src inhibitor (PP2), the interaction of 2 integrin and FAK was preserved.

View larger version (31K): [in this window] [in a new window]   Figure 7. G12 stimulates loss of FAK and paxillin phosphorylation and attachment is partially restored with protein phosphatase inhibition. (A) Results of the phosphoprotein screen (Kinexus) for QL12-MDCK cells ± dox. Relative to +dox, in QL12-expressing MDCK cells (–dox), there was a 52% reduction in pTyr-397 FAK phosphorylation and a 27% reduction in pTyr 118 of paxillin. (B) Left, FAK is dephosphorylated with G12 activation. Tet-off, G12-, and QL12-MDCK cells ± dox were analyzed in triplicate, and representative Western blots for each FAK phosphorylation are shown. Right, bar graphs summarize three independent experiments (mean ± SEM) for each phosphorylation site and are normalized to the +dox condition. (C) Left, paxillin p118 phosphorylation is reduced with QL12 expression and a representative Western is shown; right, the bar graph shows the mean ± SEM for three independent experiments. (D) QL12-stimulated loss of cell attachment to collagen-I is partially reversed with sodium orthovanadate. Tet-off, G12-, and QL12-MDCK cells ± dox were pretreated with sodium orthovanadate (100 µM) for 30 min after detachment and before measuring cell attachment on collagen-I.

G12 Regulates Cell Attachment and 2/FAK Interactions through Rho and Src Pathways

G12 Regulates FAK and Paxillin Phosphorylation: Evidence for Activation of a Tyrosine Phosphatase
To gain insights in to the mechanisms of G12 regulation of MDCK cell migration, a phosphoprotein screen (Kinexus, Vancouver, BC, Canada) was performed on QL12-MDCK cells in ±dox and was previously described (Yanamadala et al., 2007). This screen revealed decreased tyrosine phosphorylation of paxillin (pTyr118) and FAK (pTyr397) in QL12-expressing MDCK cells (–dox, Figure 7A). To confirm and extend these results, we carefully examined FAK and paxillin tyrosine phosphorylation in Tet-off, G12-, and QL12-MDCK cells ± dox and then determined relative levels of pTyr at each site by Western blot with phospho-specific antibodies. Figure 7B shows that in QL12 –dox MDCK cells there was significant inhibition of FAK phosphorylation on all tested phosphorylation sites (pTyr397, pTyr407, pTyr576-577, and pTyr861). In MDCK cells expressing wild-type G12, the effects were subtle, with only decreased phosphorylation on pTyr861 being significant. These findings are consistent with the partial phenotype seen in G12-MDCK cells. For paxillin phosphorylation, there was a significant decrease in pTyr118 in QL12-MDCK–expressing cells with no significant change in the G12-MDCK cells (Figure 7C). The loss of important tyrosine phosphorylation on key residues of FAK and paxillin suggests that G12-activated pathways include activation of a protein tyrosine phosphatase. To test for the potential role of a tyrosine phosphatase in G12-stimulated MDCK cells grown on collagen-I, we examined MDCK cell adhesion to collagen-I in the presence and absence of sodium orthovanadate, a nonspecific inhibitor of protein tyrosine phosphatases. Figure 7D shows that the inhibitor had minor effects on Tet-off, G12-, or QL12-MDCK cells in +dox. In –dox, the expected loss of attachment was seen in G12- and QL12-MDCK cells (similar to Figures 1 and 6). Pretreatment of QL12-MDCK in –dox with 100 µM sodium orthovanadate partially (but significantly) rescued the attachment phenotype, and a smaller effect was seen in the G12-MDCK cells. Taken together, these findings are consistent with G12 activation of Rho and Src signaling pathways that lead to activation of a protein tyrosine phosphatase(s), loss of tyrosine phosphorylation on FAK and paxillin, resulting in altered 2β1 function and decreased attachment to collagen-I (see also Figure 9).

Stimulating G12 Inhibits Tubulogenesis in 3D Culture and Leads to Formation of Cystic Structures
To test whether these mechanisms were important in a model of epithelial morphogenesis, we characterized the effects of G12 activation on tubulogenesis using the MDCK cell 3D tubulogenesis assay. This model of tubule development utilizes collagen-I in the matrix and HGF stimulation and depends on several integrin families including 2β1 integrin. G12- and QL12-MDCK cells ± dox were cultured in 3D collagen-I with HGF for 7 d. Figure 8A shows that G12-MDCK cells formed branching tubules, and there were no significant differences in ±dox (Figure 8A). In QL12-MDCK cells, tubulogenesis was similar to the G12 control cells in +dox (Figure 8Ac), but with induction of QL12 (–dox), very few tubular structures were identified, and nearly all structures appeared as large multicellular structures consistent with cysts (Figure 8Ad). To further define the cyst-like structures seen with QL12 expression, confocal microscopy of E-cadherin stained 3D collagen-I gels was performed after 7 d in ±dox. Figure 8B shows a branching structure in QL12 +dox with E-cadherin staining outlining the tubule surface. With QL12 expression (–dox), a circumferential ring of E-cadherin–positive cells lined the cyst with no detectable intracystic staining, consistent with a cell-free lumen surrounded by epithelial cells. To determine whether activation of endogenous G12 regulates tubulogenesis, we utilized thrombin and bradykinin as described for Figure 1. Figure 8C shows that thrombin but not bradykinin significantly reduced the number of tubular structures and increased the number of cysts. However, the morphology of thrombin-stimulated cystic structures was subtly different from the G12-stimulated cysts (Figure 8Cb); they were slightly smaller and contained short linear extensions from the central body. To confirm that G12 activation leads to impaired tubulogenesis and the formation of cystic structures, the 3D tubulogenesis assay was repeated using the shG12-MDCK cells shown in Figure 8D. Control and G12-silenced MDCK cells were cultured ± thrombin as described above. After 7 d, tubulogenesis was well developed in both the control cells and in G12-silenced MDCK cells in the absence of thrombin. With thrombin stimulation, the control cells formed cystic structures similar to those seen in Figure 8, A and C, but thrombin stimulated loss of tubulogenesis, and the formation of cystic structures was significantly reduced in the G12-silenced cells (Figure 8Dd). Taken together, these findings are consistent with those showing that activated G12 inhibits tubulogenesis and promotes the formation of cystic structures.

View larger version (86K): [in this window] [in a new window]   Figure 8. G12 regulates tubulogenesis. (A) Tubulogenesis assay with G12- and QL12-MDCK cells ± dox. G12- and QL12-MDCK cells ± dox (4 x 104 cells) were trypsinized, washed, and mixed with 3D gel (3.5 mg/ml collagen-I, 20 ng/ml HGF with HEPES buffer in DMEM, and ±dox) as described in Materials and Methods. Phase-contrast microscopy after 7 d in culture; (a) G12 +dox; (b) G12 –dox; (c) QL12 +dox; and (d) QL12 –dox. Representative images are shown. Bar, 100 µm. (B) 3D cultures were stained with E-cadherin and imaged by confocal microscopy as described in Materials and Methods. Bar, 15 µm. (C) Thrombin inhibits tubulogenesis assay in control MDCK cells (Tet-off). Tubulogenesis assay with Tet-off MDCK cells stimulated with (a) vehicle, (b) thrombin (2 U/ml), or (c) bradykinin (100 µM) for 7 d. Bar, 100 µm. (D) G12-silenced MDCK cells are resistant to cyst development. shG12- and shGFP-MDCK cells (Control shRNA) were cultured ± thrombin for 7 d in 3D tubulogenesis assay (a–d). Bar, 25 µM.

	DISCUSSION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

View larger version (20K): [in this window] [in a new window]   Figure 9. Model of regulation: a schematic summary of the findings in this study revealing inside-out signaling through G12 to disrupt focal adhesions and the loss of integrin–collagen-I binding. Activation of G12 (by thrombin or QL mutation) activates Rho and Src leading to inhibition of FAK and disruption of the FAK–integrin complex. Once the FAK–integrin complex is disrupted, the focal adhesion complex comes apart and 2β1 integrin can no longer interact with collagen-I in the matrix. The link from Rho and Src activation to inhibition of FAK is likely mediated by intermediate signaling molecules and involves a protein tyrosine phosphatase.

To our knowledge, this is the first report of G protein regulation of integrins in epithelial cells. We identified specific regulation of MDCK cell interactions on collagen-I (not collagen-IV) that were G12 regulated. This suggests important specificity in G protein regulation of integrins, although we also found G12-dependent attachment to laminin-1 and -5 (Figure 1 and Supplemental Figure S1). These findings raise the possibility that G12 may also regulate other integrins such as 6β1 for laminin-1 and 6β4 or 3β1 for laminin-5. These findings are likely to be important in numerous contexts including epithelial migration during development and after injury, where the unique composition of the extracellular matrix will determine engagement of specific integrins. Additional studies will be necessary to explore these other mechanisms. In other cell types, there are well-characterized examples of G protein regulation of integrin function. In leukocytes, chemokine stimulated G protein–coupled receptors play a major role in regulating integrin activity and lymphocyte migration. In splenic B cells, lysophosphatidic acid regulated integrin-mediated adhesion through Gi and G12/13 pathways (Rieken et al., 2006). In platelets, integrin-mediated aggregation can be stimulated with thrombin, ADP, epinephrine, thromboxane, and other agonists that utilize numerous G protein–coupled pathways. Costimulation of G12/13 and Gi pathways (with thromboxane A₂ and ADP) led to irreversible integrin (IIbβ3)-mediated aggregation (Dorsam et al., 2002; Nieswandt et al., 2002).

Attachment and adhesion are critical steps in cell migration and G proteins are important in cell migration in several different cell types. In human 1321N1 astrocytoma cells, the P2Y₂ nucleotide receptor interacts with V integrins to induce chemotaxis. P2Y₂R also requires V integrin to activate G12 and Rho pathways required for cytoskeletal rearrangements leading to chemotaxis (Liao et al., 2007). In migrating leukocytes, the leading edge is dependent on Gi-mediated production of 3'-phosphoinositol lipids and activated Rac. The trailing edge uses G12/13 regulation of Rho, and both systems coordinate differential regulation of the actin cytoskeleton in the presence of a chemoattractant (Xu et al., 2003). Using mouse embryonic fibroblast-derived G12/13 knockout mice, Goulimari showed that G12/13 were required for directed cell migration. Cells lacking G12/13 were unable to localize active Rho or its effector mDia at the wound edge (Goulimari et al., 2005). G12/13-deficient fibroblasts were severely impaired in closing the gap in wound-healing assays, and the cells on the leading edge were unable to migrate in to the wounded area. On the basis of these observations, one might expect that activating G12 would lead to more rapid wound closure, not the inhibition that was observed in invasion and wound assays. However, there are several potential explanations for why both knockout cells and cells with an activated G12 might reveal a phenotype of impaired migration. First, it is likely that defects in any one of numerous critical cellular processes can result in failed migration. There are also likely to be important differences between fibroblasts and epithelial cells in the mechanisms utilized for directional migration and establishment of polarity. The defect we observe with G12 activation in MDCK cells is disruption of the focal adhesion protein complex and impaired lamellipodia formation. In contrast, the G12/13 knockout fibroblasts are lacking both G12 and G13 subunits, and these cells have impaired directional migration without any disruption of cellular process formation. MDCK cells with activated G12 appeared to have very few cellular processes at all.

The model suggested by our studies (Figure 9) indicates G12-stimulated Rho and Src leads to decreased phosphorylation of FAK and paxillin and disruption of the FAK–integrin complex. Tyrosine phosphorylation of FAK (tyr-397, -576, -577, -861, and -925) and paxillin (tyr-118) is required for assembly of the focal adhesion complex (reviewed in Mitra et al., 2005). The finding of decreased tyrosine phosphorylation of these proteins with G12 activation is consistent with decreased migration and loss of focal adhesions. Although there was slightly decreased phosphorylation of Fak pTyr577 and paxillin pTyr118 in G12-expressing cells, only FAK pTyr861 was significant. Phosphorylation of FAK Tyr861 is important for assembling the protein complex necessary for cell (Kiyokawa et al., 1998) migration (Kiyokawa et al., 1998). Fibroblasts expressing a mutant FAK (Phe861) show decreased migration (Lim et al., 2004) and in breast cancer cells, pTyr861 plays a role in transendothelial migration (Earley and Plopper, 2008). Therefore, G12 regulation of these phosphorylations are likely to be important to the observed phenotypes in G12- and QL12-MDCK cells. However, FAK pTyr397 and others (including pTyr861) are typically phosphorylated with Src activation, and Src can be directly activated by G12 (Ma et al., 2000). Therefore, this traditional signaling mechanism cannot account for the decreased phosphorylation of FAK and paxillin that was observed (Figure 7, B and D). One possible explanation is that we are measuring total cellular Src activity with QL12 expression, and the local activity in the focal adhesion complex may be different (inhibited). Another possibility is G12 activation of Rho and/or Src leads to activation of a protein tyrosine phosphatase, and the results with sodium orthovanadate supports this possibility (Figure 7D). In cells overexpressing FAK, regulation of pTyr576-577 by a protein phosphatase was suggested by treatment with orthovanadate (Earley and Plopper, 2008), and sodium orthovanadate is known to be a broad inhibitor of protein tyrosine phosphatases. The mechanisms of focal adhesion complex assembly are known in some detail, yet there is little known about the phosphatases regulating focal adhesions. The nontransmembrane phosphotyrosyl phosphatase, SHP-2, is widely expressed and was shown to be required for cell migration and branching morphogenesis in MDCK cell 3D culture (Wang et al., 2006). SHP-2 associates with FAK in HCA-7 cells and directly tyrosine dephosphorylated FAK in vitro (Khare et al., 2006). In addition, there is evidence that Src can activate SHP-1 in embryonic tissues (Alvarez et al., 2008), suggesting the possibility that Src may stimulate SHP-2 in other contexts. Another phosphatase (low-molecular-weight phosphotyrosine protein phosphatase) was shown to regulate FAK phosphorylation in a Src-dependent manner, and overexpression led to decreased cell spreading and decreased focal adhesions (Rigacci et al., 2002). Additional studies will be needed to address these potential mechanisms and identify the relevant protein tyrosine phosphatase(s).

The finding that this signaling pathway is likely to involve a protein phosphatase is consistent with several other reports linking G12 signaling to protein phosphatases. We identified direct binding of G12 to the scaffolding (A) subunit of the serine/threonine phosphatase PP2A and demonstrated that G12-stimulated phosphatase activity (Zhu et al., 2004, 2007). Activated G12 and G13 have been shown to bind and stimulate the PP5 family of serine/threonine phosphatases (Yamaguchi et al., 2002, 2003) through an interaction with the TPR (tetratricopeptide repeat) domain. These observations, in addition to the studies presented here, suggest that G12/13 may be important regulators of cellular phosphatases. The findings in this report are the first to implicate regulation of a protein tyrosine phosphatase, and the G12 regulation in this case is likely to be indirect.

The pathophysiologic implications for these studies extend beyond potential roles in metastatic epithelial cancers. The 3D collagen-I gel model of branching morphogenesis in MDCK cells has been widely utilized because it recapitulates many of the in vivo steps that are seen with the iterative branching morphogenesis of the ureteric bud. Work from many laboratories reveals a multistep process that requires cell adhesion to the extracellular matrix, cell spreading, and cell migration to form tube-like structures. In addition, there is a balance between proliferation and apoptosis required for successful tubule development (reviewed in Pohl et al., 2000; O'Brien et al., 2002). Integrins are essential for branching tubulogenesis in 3D collagen-I culture and the 1,2β1 integrins are required along with other integrin families that utilize laminin receptors (3β1, 6β1, and 6β4 integrins) (Chen et al., 2004). Our finding of impaired tubulogenesis and increased cyst-like structures reveals novel regulation of integrins through activation of G12 and inhibition 2β1 function in 3D collagen-I matrix. Activated Rho may also contribute to the defective tubule formation seen in QL12-MDCK cells. Loss of FAK leads to activation of Rho and inhibition of focal adhesion turnover (Ren et al., 1999), and RhoA inactivation is necessary for cell spreading and migration (Arthur and Burridge, 2001). Integrins normally trigger inhibition of RhoA through Src-dependent activation of p190RhoGAP (Arthur et al., 2000), and this inhibition is likely to be blocked in this model with G12 activation.

The cysts seen in the 3D tubulogenesis assays with G12 activation raises the possibility that G12 could play a role in the development of cystic kidney diseases. PC1 encodes a large transmembrane protein, polycystin-1 (PC1), that is localized to cilia, adherens junctions, and the basal membrane of renal epithelia. PC1 has a short intracellular cytoplasmic domain that binds to G12 (Yuasa et al., 2004). Mutations in PC1 mutations are responsible for the majority of patients with ADPKD, and several studies have linked changes in integrin expression and function in ADPKD. Similar to what we observe with G12-stimulated inhibition of 2β1 integrin function, studies with MDCK cells transfected with antisense RNA for 2 integrins led to reduced adhesion to collagen-I, decreased tubulogenesis, and the formation of cyst-like structures in 3D (Saelman et al., 1995). In MDCK cells with silenced PC1 expression, tubulogenesis was inhibited and there was increased adhesion to collagen-I associated with up-regulation of 2β1 integrin protein level (Battini et al., 2006). In addition to MDCK cell models, there is also evidence for a PC1-2-integrin link. In human immortalized renal epithelial cell lines derived from normal kidney and ADPKD kidneys, ADPKD renal cells showed increased adhesion to collagen-I and showed increased levels of 2β1 integrin expression when compared with controls. Confocal microscopy revealed colocalization of 2β1 integrins and PC1 along with vinculin in focal adhesions (Wilson et al., 1999). Furthermore, the impaired cell migration observed in QL12-MDCK cells, and the increased Rho activity may contribute to cyst development. In support of this possibility, we find that inhibiting Rho in Pkd1 mutant mouse embryonic kidney cells (Pkd1–/–) growing in 3D collagen-I culture leads to a reversal of the cystic phenotype and the development of a branching morphology. This suggests that G12/Rho activation may be required for the maintenance of cystogenesis (unpublished data). These findings, taken together, lead us to speculate that there is important regulation of epithelial cell functions through PC1/G12.

In conclusion, we find that G12 inhibits 2β1 integrins in epithelial cells and leads to defects in cell spreading that impairs cell migration and prevents tubulogenesis in 3D culture. These findings provide novel insights into epithelial cell functions that are likely to be important in several areas of epithelial pathobiology and include metastasis, tubulogenesis during renal development, recovery from acute kidney injury and in the pathogenesis of polycystic kidney disease. Strategies to block G12 signaling may hold promise for treating the adverse consequences seen in these disorders.

	ACKNOWLEDGMENTS

 
We thank members of the Harvard Polycystic Kidney Disease Center for helpful comments and suggestions, Dr. Gunaratnam for providing G12-expressing PK1 cells, and Sarah Beaudry for her outstanding technical assistance. This work was supported by Grants P50 DK074030 to J.Z. (PI) and B.M.D. (Project 1). J.Z. is also supported by R01 KD40703 and B.M.D. by R01 GM5223, and Grant K01 DK080179 to T.K.

	Footnotes

 
This was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E09-03-0220) on September 23, 2009.

Address correspondence to: Bradley M. Denker (bdenker{at}rics.bwh.harvard.edu).

Abbreviations used: dox, doxycycline; ADPKD, autosomal dominant polycystic kidney disease.

	REFERENCES

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Alvarez, S. E., Seguin, L. R., Villarreal, R. S., Nahmias, C., and Ciuffo, G. M. (2008). Involvement of c-Src tyrosine kinase in SHP-1 phosphatase activation by Ang II AT2 receptors in rat fetal tissues. J. Cell. Biochem 105, 703–711.[CrossRef][Medline]

Arthur, W. T., and Burridge, K. (2001). RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. Mol. Biol. Cell 12, 2711–2720.[Abstract/Free Full Text]

Arthur, W. T., Petch, L. A., and Burridge, K. (2000). Integrin engagement suppresses RhoA activity via a c-Src-dependent mechanism. Curr. Biol 10, 719–722.[CrossRef][Medline]

Battini, L., Fedorova, E., Macip, S., Li, X., Wilson, P. D., and Gusella, G. L. (2006). Stable knockdown of polycystin-1 confers integrin-2β1-mediated anoikis resistance. J. Am. Soc. Nephrol 17, 3049–3058.[Abstract/Free Full Text]

Boca, M., D'Amato, L., Distefano, G., Polishchuk, R. S., Germino, G. G., and Boletta, A. (2007). Polycystin-1 induces cell migration by regulating phosphatidylinositol 3-kinase-dependent cytoskeletal rearrangements and GSK3β-dependent cell cell mechanical adhesion. Mol. Biol. Cell 18, 4050–4061.[Abstract/Free Full Text]

Buhl, A. M., Johnson, N. L., Dhanasekaran, N., and Johnson, G. L. (1995). G12 and G13 stimulate Rho-dependent stress fiber formation and focal adhesion assembly. J. Biol. Chem 270, 24631–24634.[Abstract/Free Full Text]

Chen, D. et al. (2004). Differential expression of collagen- and laminin-binding integrins mediates ureteric bud and inner medullary collecting duct cell tubulogenesis. Am. J. Physiol. Renal. Physiol 287, F602–F611.[Abstract/Free Full Text]

Dorsam, R. T., Kim, S., Jin, J., and Kunapuli, S. P. (2002). Coordinated signaling through both G12/13 and G(i) pathways is sufficient to activate GPIIb/IIIa in human platelets. J. Biol. Chem 277, 47588–47595.[Abstract/Free Full Text]

Earley, S., and Plopper, G. E. (2008). Phosphorylation of focal adhesion kinase promotes extravasation of breast cancer cells. Biochem. Biophys. Res. Commun 366, 476–482.[CrossRef][Medline]

Goulimari, P., Kitzing, T. M., Knieling, H., Brandt, D. T., Offermanns, S., and Grosse, R. (2005). G12/13 is essential for directed cell migration and localized Rho-Dia1 function. J. Biol. Chem 280, 42242–42251.[Abstract/Free Full Text]

Hynes, R. O. (2002). Integrins: bidirectional, allosteric signaling machines. Cell 110, 673–687.[CrossRef][Medline]

Joly, D., Morel, V., Hummel, A., Ruello, A., Nusbaum, P., Patey, N., Noel, L. H., Rousselle, P., and Knebelmann, B. (2003). β4 integrin and laminin 5 are aberrantly expressed in polycystic kidney disease: role in increased cell adhesion and migration. Am. J. Pathol 163, 1791–1800.[Abstract/Free Full Text]

Kelly, P., Casey, P. J., and Meigs, T. E. (2007). Biologic functions of the G12 subfamily of heterotrimeric G proteins: growth, migration, and metastasis. Biochemistry 46, 6677–6687.[CrossRef][Medline]

Kelly, P., Moeller, B. J., Juneja, J., Booden, M. A., Der, C. J., Daaka, Y., Dewhirst, M. W., Fields, T. A., and Casey, P. J. (2006a). The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis. Proc. Natl. Acad. Sci. USA 103, 8173–8178.[Abstract/Free Full Text]

Kelly, P., Stemmle, L. N., Madden, J. F., Fields, T. A., Daaka, Y., and Casey, P. J. (2006b). A role for the G12 family of heterotrimeric G proteins in prostate cancer invasion. J. Biol. Chem 281, 26483–26490.[Abstract/Free Full Text]

Khare, S., Holgren, C., and Samarel, A. M. (2006). Deoxycholic acid differentially regulates focal adhesion kinase phosphorylation: role of tyrosine phosphatase ShP2. Am. J. Physiol. Gastrointest. Liver Physiol 291, G1100–G1112.[Abstract/Free Full Text]

Kiyokawa, E., Hashimoto, Y., Kobayashi, S., Sugimura, H., Kurata, T., and Matsuda, M. (1998). Activation of Rac1 by a Crk SH3-binding protein, DOCK180. Genes Dev 12, 3331–3336.[Abstract/Free Full Text]

Kolesnikova, T. V., Mannion, B. A., Berditchevski, F., and Hemler, M. E. (2001). β1 integrins show specific association with CD98 protein in low density membranes. BMC Biochem 2, 10.[CrossRef][Medline]

Kozasa, T., Jiang, X., Hart, M. J., Sternweis, P. M., Singer, W. D., Gilman, A. G., Bollag, G., and Sternweis, P. C. (1998). p115 RhoGEF, a GTPase activating protein for G12 and G13. Science 280, 2109–2111.[Abstract/Free Full Text]

Liao, Z., Seye, C. I., Weisman, G. A., and Erb, L. (2007). The P2Y2 nucleotide receptor requires interaction with v integrins to access and activate G12. J. Cell Sci 120, 1654–1662.[Abstract/Free Full Text]

Lim, Y., Han, I., Jeon, J., Park, H., Bahk, Y. Y., and Oh, E. S. (2004). Phosphorylation of focal adhesion kinase at tyrosine 861 is crucial for Ras transformation of fibroblasts. J. Biol. Chem 279, 29060–29065.[Abstract/Free Full Text]

Ma, Y. C., Huang, J., Ali, S., Lowry, W., and Huang, X. Y. (2000). Src tyrosine kinase is a novel direct effector of G proteins. Cell 102, 635–646.[CrossRef][Medline]

Meigs, T. E., Fedor-Chaiken, M., Kaplan, D. D., Brackenbury, R., and Casey, P. J. (2002). G12 and G13 negatively regulate the adhesive functions of cadherin. J. Biol. Chem 277, 24594–24600.[Abstract/Free Full Text]

Meyer, T. N., Hunt, J., Schwesinger, C., and Denker, B. M. (2003). G12 regulates epithelial cell junctions through Src tyrosine kinases. Am. J. Physiol. Cell Physiol 285, C1281–C1293.[Abstract/Free Full Text]

Meyer, T. N., Schwesinger, C., and Denker, B. M. (2002). Zonula occludens-1 is a scaffolding protein for signaling molecules. G12 directly binds to the Src homology 3 domain and regulates paracellular permeability in epithelial cells. J. Biol. Chem 277, 24855–24858.[Abstract/Free Full Text]

Mitra, S. K., Hanson, D. A., and Schlaepfer, D. D. (2005). Focal adhesion kinase: in command and control of cell motility. Nat. Rev. Mol. Cell Biol 6, 56–68.[CrossRef][Medline]

Nieswandt, B., Schulte, V., Zywietz, A., Gratacap, M. P., and Offermanns, S. (2002). Costimulation of Gi- and G12/G13-mediated signaling pathways induces integrin IIb β3 activation in platelets. J. Biol. Chem 277, 39493–39498.[Abstract/Free Full Text]

O'Brien, L. E., Zegers, M. M., and Mostov, K. E. (2002). Opinion: Building epithelial architecture: insights from three-dimensional culture models. Nat. Rev. Mol. Cell Biol 3, 531–537.[CrossRef][Medline]

Pohl, M., Stuart, R. O., Sakurai, H., and Nigam, S. K. (2000). Branching morphogenesis during kidney development. Annu. Rev. Physiol 62, 595–620.[CrossRef][Medline]

Pollack, A. L., Runyan, R. B., and Mostov, K. E. (1998). Morphogenetic mechanisms of epithelial tubulogenesis: MDCK cell polarity is transiently rearranged without loss of cell-cell contact during scatter factor/hepatocyte growth factor-induced tubulogenesis. Dev. Biol 204, 64–79.[CrossRef][Medline]

Ren, X. D., Kiosses, W. B., and Schwartz, M. A. (1999). Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J 18, 578–585.[CrossRef][Medline]

Rieken, S., Herroeder, S., Sassmann, A., Wallenwein, B., Moers, A., Offermanns, S., and Wettschureck, N. (2006). Lysophospholipids control integrin-dependent adhesion in splenic B cells through G(i) and G(12)/G(13) family G-proteins but not through G(q)/G(11). J. Biol. Chem 281, 36985–36992.[Abstract/Free Full Text]

Rigacci, S., Rovida, E., Dello Sbarba, P., and Berti, A. (2002). Low Mr phosphotyrosine protein phosphatase associates and dephosphorylates p125 focal adhesion kinase, interfering with cell motility and spreading. J. Biol. Chem 277, 41631–41636.[Abstract/Free Full Text]

Riobo, N. A., and Manning, D. R. (2005). Receptors coupled to heterotrimeric G proteins of the G12 family. Trends Pharmacol. Sci 26, 146–154.[CrossRef][Medline]

Sabath, E., Negoro, H., Beaudry, S., Paniagua, M., Angelow, S., Shah, J., Grammatikakis, N., Yu, A. S., and Denker, B. M. (2008). G12 regulates protein interactions within the MDCK cell tight junction and inhibits tight-junction assembly. J. Cell Sci 121, 814–824.[Abstract/Free Full Text]

Saelman, E. U., Keely, P. J., and Santoro, S. A. (1995). Loss of MDCK cell 2β1integrin expression results in reduced cyst formation, failure of hepatocyte growth factor/scatter factor-induced branching morphogenesis, and increased apoptosis. J. Cell Sci 108, (Pt 11), 3531–3540.[Abstract]

Wang, C. Z., Su, H. W., Hsu, Y. C., Shen, M. R., and Tang, M. J. (2006). A discoidin domain receptor 1/SHP-2 signaling complex inhibits 2β1-integrin-mediated signal transducers and activators of transcription 1/3 activation and cell migration. Mol. Biol. Cell 17, 2839–2852.[Abstract/Free Full Text]

Wang, X. Q., and Frazier, W. A. (1998). The thrombospondin receptor CD47 (IAP) modulates and associates with 2β1 integrin in vascular smooth muscle cells. Mol. Biol. Cell 9, 865–874.[Abstract/Free Full Text]

Wilson, P. D., Geng, L., Li, X., and Burrow, C. R. (1999). The PKD1 gene product, "polycystin-1," is a tyrosine-phosphorylated protein that colocalizes with 2β1-integrin in focal clusters in adherent renal epithelia. Lab. Invest 79, 1311–1323.[Medline]

Xu, J. et al. (2003). Divergent signals and cytoskeletal assemblies regulate self-organizing polarity in neutrophils. Cell 114, 201–214.[CrossRef][Medline]

Yamaguchi, Y., Katoh, H., Mori, K., and Negishi, M. (2002). G(12) and G(13) interact with Ser/Thr protein phosphatase type 5 and stimulate its phosphatase activity. Curr. Biol 12, 1353–1358.[CrossRef][Medline]

Yamaguchi, Y., Katoh, H., and Negishi, M. (2003). N-terminal short sequences of subunits of the G12 family determine selective coupling to receptors. J. Biol. Chem 278, 14936–14939.[Abstract/Free Full Text]

Yanamadala, V., Negoro, H., Gunaratnam, L., Kong, T., and Denker, B. M. (2007). G12 stimulates apoptosis in epithelial cells through JNK1-mediated Bcl-2 degradation and up-regulation of IkB. J. Biol. Chem 282, 24352–24363.[Abstract/Free Full Text]

Yang, X. H., Richardson, A. L., Torres-Arzayus, M. I., Zhou, P., Sharma, C., Kazarov, A. R., Andzelm, M. M., Strominger, J. L., Brown, M., and Hemler, M. E. (2008). CD151 accelerates breast cancer by regulating 6 integrin function, signaling, and molecular organization. Cancer Res 68, 3204–3213.[Abstract/Free Full Text]

Yuasa, T., Takakura, A., Denker, B. M., Venugopal, B., and Zhou, J. (2004). Polycystin-1L2 is a novel G-protein-binding protein. Genomics 84, 126–138.[CrossRef][Medline]

Zhu, D., Kosik, K. S., Meigs, T. E., Yanamadala, V., and Denker, B. M. (2004). G12 directly interacts with PP2A: evidence for G12-stimulated PP2A phosphatase activity and dephosphorylation of microtubule-associated protein, tau. J. Biol. Chem 279, 54983–54986.[Abstract/Free Full Text]

Zhu, D., Tate, R. I., Ruediger, R., Meigs, T. E., and Denker, B. M. (2007). Domains necessary for G12 binding and stimulation of protein phosphatase-2A (PP2A): is G12 a novel regulatory subunit of PP2A? Mol. Pharmacol 71, 1268–1276.[Abstract/Free Full Text]

Zylstra, S., Chen, F. A., Ghosh, S. K., Repasky, E. A., Rao, U., Takita, H., and Bankert, R. B. (1986). Membrane-associated glycoprotein (gp 160) identified on human lung tumors by a monoclonal antibody. Cancer Res 46, 6446–6451.[Abstract/Free Full Text]

This Article Abstract Full Text (PDF) Supplemental Materials All Versions of this Article: E09-03-0220v1 20/21/4596    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kong, T. Articles by Denker, B. M. Search for Related Content PubMed PubMed Citation Articles by Kong, T. Articles by Denker, B. M.